benign prostatic hyperplasia

PHILADELPHIA, July 16, 2026 Medicus Pharma announced that it has received written feedback from the U.S. Food and Drug...

BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...

SAN JOSE, Calif., May 14, 2026 Resurge Therapeutics announced positive clinical findings from two studies evaluating its proprietary IntraProstatic...